Article

IL-21 promotes lupus-like disease in chronic graft-versus-host disease through both CD4 T cell- and B cell-intrinsic mechanisms.

Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
The Journal of Immunology (Impact Factor: 5.52). 06/2012; 189(2):1081-93. DOI: 10.4049/jimmunol.1200318
Source: PubMed

ABSTRACT T cell-driven B cell hyperactivity plays an essential role in driving autoimmune disease development in systemic lupus erythematosus. IL-21 is a member of the type I cytokine family with pleiotropic activities. It regulates B cell differentiation and function, promotes T follicular helper (T(FH)) cell and Th17 cell differentiation, and downregulates the induction of T regulatory cells. Although IL-21 has been implicated in systemic lupus erythematosus, the relative importance of IL-21R signaling in CD4(+) T cells versus B cells is not clear. To address this question, we took advantage of two induced models of lupus-like chronic graft-versus-host disease by using wild-type or IL-21R(-/-) mice as donors in the parent-into-F1 model and as hosts in the Bm12→B6 model. We show that IL-21R expression on donor CD4(+) T cells is essential for sustaining T(FH) cell number and subsequent help for B cells, resulting in autoantibody production and more severe lupus-like renal disease, but it does not alter the balance of Th17 cells and regulatory T cells. In contrast, IL-21R signaling on B cells is critical for the induction and maintenance of germinal centers, plasma cell differentiation, autoantibody production, and the development of renal disease. These results demonstrate that IL-21 promotes autoimmunity in chronic graft-versus-host disease through both CD4(+) T cell- and B cell-intrinsic mechanisms and suggest that IL-21 blockade may attenuate B cell hyperactivity, as well as the aberrant T(FH) cell pathway that contributes to lupus pathogenesis.

0 Bookmarks
 · 
95 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Dear Editor, Recently, we read with great interest the article entitled “Decreased serum level of IL-21 in new-onset systemic lupus erythematosus patients,” published in Rheumatol Int, showing that interleukin-21(IL-21) levels were significantly decreased in the serum of patients with systemic lupus erythematosus (SLE) compared with controls [1]. However, there was no significant difference regarding serum IL-21 level between SLE patients with nephritis and those without nephritis. Furthermore, no significant difference was found between less active SLE and more active SLE [1]. These findings suggest that IL-21 may play a crucial role in the pathogenesis of SLE, and serum level of IL-21 may be a diagnostic and therapeutic target in human SLE. Interleukin-21 is the most recently discovered member of the type-I cytokine family with pleiotropic activities [2]. Recently, Nguyen et al. [3] have demonstrated that aberrant IL-21 activity may contribute to the development and pathogenesis of a
    Rheumatology International 09/2013; · 2.21 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Induced mouse models of systemic lupus erythematosus (SLE) have been developed to complement the spontaneous models. This chapter describes the methods used in the pristane-induced model and the chronic graft-versus-host disease (cGVHD) model, both of which have been extensively used. We will also outline the specific mechanisms of systemic autoimmunity that can be best characterized using each of these models.
    Methods in molecular biology (Clifton, N.J.) 01/2014; 1134:103-30. · 1.29 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Autoimmune responses mediated by CD4+ T cells may contribute to the development of chronic obstructive pulmonary disease (COPD). However, little is known about the frequency of peripheral blood Th17 cells and Tregs in Chinese patients with COPD. This study is aimed at determining the frequency of circulating Th17 and Tregs in patients with moderate and severe COPD, heavy smokers, and healthy controls (HC).Method The percentages of circulating Th17 cells and Tregs were determined by flow cytometry in 32 patients with moderate COPD, 33 patients with severe COPD, 35 smokers, and 31 HC. The concentrations of serum Th17- and Treg-related cytokines were measured by enzyme-linked immunosorbent assay (ELISA). The levels of retinoic acid orphan receptor (ROR)-γt and Forkhead box (Fox) p3 mRNA transcripts in peripheral blood mononuclear cells were determined by real-time PCR. The potential correlation between the percentages of Th17 Tregs, serum cytokines and lung function was evaluated.ResultsIn comparison with that in the smokers and HC, significantly higher frequencies of Th17 cells and higher levels of ROR-γt mRNA transcripts and serum IL-17A, IL-6, IL-21, IL-22 and IL-23, but lower frequency of Tregs and lower levels of Foxp3 and serum IL-10 were detected in patients with moderate and severe COPD. The increased ratios of Th17 to Tregs were negatively correlated with the values of FVC, FEV1, and FEV1/FVC.Conclusions An imbalance of circulating Th17 cells and Tregs is associated with the deterioration of pulmonary function in patients with moderate and severe COPD.
    The Clinical Respiratory Journal 04/2014; · 1.66 Impact Factor

Similar Publications